What strategies do you employ to overcome the barrier of insurance approval for infections that can be appropriately treated with non-generic oral antibiotics in place of intravenous therapy?

How do you handle a situation when the oral antibiotics, which will work in place of continued IV antibiotic therapy, are branded, but getting approval from the insurance company is difficult to impossible?

• 1. Fight hard for prior approval.
• Other